Stock A128940 HANMI PHARM. CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hanmi Pharm. Co., Ltd.

Equities

A128940

KR7128940004

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 26/04/2024 am IST 		5-day change 1st Jan Change
3,10,500 KRW +0.16% Intraday chart for Hanmi Pharm. Co., Ltd. +0.65% -11.91%
19/03 Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
31/01 Aptose Biosciences Inc. announced that it has received $4 million in funding from Hanmi Pharm. Co., Ltd. CI

Business Summary

Hanmi Pharm Co Ltd is a Korea-based company principally engaged in the manufacturing and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceuticals segment manufactures and sells tablets, capsules, injections, syrups, powders and raw materials used in the treatment of hypertension, reflux esophagitis, influenza type A and influenza type B virus infections and hyperlipidemia, among others. The Other segment is engaged in the materials processing. The Export segment produces and sells products such as powders and injections, and exports technologies.

Number of employees: 2,238

Sales per Business

KRW in Million2022Weight2023Weight Delta
Medicine
73.0 %
975,021 73.2 % 1,087,780 73.0 % +11.56%
Overseas Medicine
26.7 %
350,640 26.3 % 397,513 26.7 % +13.37%
Drug Substance
0.4 %
5,885 0.4 % 5,594 0.4 % -4.95%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
59.7 %
826,082 62.0 % 890,760 59.7 % +7.83%
China
27.2 %
356,108 26.7 % 404,849 27.2 % +13.69%
Other
5.1 %
63,687 4.8 % 75,478 5.1 % +18.51%
United States
4.6 %
40,869 3.1 % 67,990 4.6 % +66.36%
Japan
3.5 %
44,800 3.4 % 51,811 3.5 % +15.65%

Managers

Managers TitleAgeSince
Jong-Yoon Lim CEO
 Chief Executive Officer 51 -
In-Guk Hwang CMP
 Compliance Officer 52 -
Gwi-Hyun Seo CTO
 Chief Tech/Sci/R&D Officer 62 -
Gwan-Sun Lee BRD
 Director/Board Member 64 -
Gyu-Chan Kwon PRN
 Corporate Officer/Principal 54 -
Yeong-Hoon Kim PRN
 Corporate Officer/Principal 62 -
Ju-Hyun Lim PRN
 Corporate Officer/Principal 49 -

Members of the board

Members of the board TitleAgeSince
Jong-Yoon Lim CEO
 Chief Executive Officer 51 -
Gwan-Sun Lee BRD
 Director/Board Member 64 -
Dong-Cheol Seo BRD
 Director/Board Member 68 10/17/10
Seon-Hye Hwang BRD
 Director/Board Member 70 -

Shareholders

NameEquities%Valuation
HANMI SCIENCE CO., LTD.
41.42 %
5,306,122 41.42 % 1 312 M ₩
National Pension Service of Korea
10.49 %
1,344,005 10.49 % 332 M ₩
Dong-guk Shin
7.871 %
1,008,369 7.871 % 249 M ₩
HANMI PHARM. CO., LTD.
0.9783 %
125,329 0.9783 % 31 M ₩
Nordea Investment Management AB
0.2182 %
27,958 0.2182 % 7 M ₩
Sjunde AP-fonden
0.1244 %
15,934 0.1244 % 4 M ₩
State Street Global Advisors Ltd.
0.1152 %
14,760 0.1152 % 4 M ₩
KB Asset Management Co., Ltd.
0.1005 %
12,876 0.1005 % 3 M ₩
Northern Trust Fund Managers (Ireland) Ltd.
0.0895 %
11,467 0.0895 % 3 M ₩
Goldman Sachs Asset Management International
0.0504 %
6,456 0.0504 % 2 M ₩

Holdings

NameEquities%Valuation
HANMI PHARM. CO., LTD.
0.98%
 125,329 0.98% 31,000,599 $
APTOSE BIOSCIENCES INC.
19.02%
 2,989,415 19.02% 4,962,429 $

Company contact information

Hanmi Pharmaceutical Co., Ltd.

214 Muha-ro Paltan-myeon

18536, Hwaseong-si

+82 3 1350 5600

http://www.hanmipharm.com
address Hanmi Pharm. Co., Ltd.(A128940)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Ratings for Hanmi Pharm. Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
3,10,500 KRW
Average target price
4,08,486 KRW
Spread / Average Target
+31.56%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
HANMI PHARM. CO., LTD. Stock Hanmi Pharm. Co., Ltd.
-11.91% 2.86B
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.81% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+11.79% 14.09B
CIPLA LIMITED Stock Cipla Limited
+12.97% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+39.74% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A128940 Stock
  4. Company Hanmi Pharm. Co., Ltd.